The next board meeting for ProQR Therapeutics NV is on 07 Aug 2026 for the purpose of ProQR Therapeutics NV Second Quarter Earnings Results for 2026See details
ProQR Therapeutics NV has a share price target of US$ 8, revenue growth forecast of -19.1%, and profit growth estimate of -34.7% for FY26, based on top 8 analyst calls.